Windtree Therapeutics Inc (WINT) Major Shareholder Pharmaceutical Holdings Lee’s Purchases 541,667 Shares

Windtree Therapeutics Inc (OTCMKTS:WINT) major shareholder Pharmaceutical Holdings Lee’s bought 541,667 shares of Windtree Therapeutics stock in a transaction on Wednesday, April 4th. The shares were purchased at an average price of $4.80 per share, for a total transaction of $2,600,001.60. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Shares of WINT remained flat at $$3.35 during mid-day trading on Friday. The stock had a trading volume of 1,221 shares, compared to its average volume of 2,234. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of -0.33. Windtree Therapeutics Inc has a 12-month low of $2.60 and a 12-month high of $33.20.

How to Become a New Pot Stock Millionaire

Separately, ValuEngine raised Windtree Therapeutics from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/3336043/windtree-therapeutics-inc-wint-major-shareholder-pharmaceutical-holdings-lees-purchases-541667-shares.html.

About Windtree Therapeutics

Windtree Therapeutics, Inc, formerly Discovery Laboratories, Inc, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment.

Receive News & Ratings for Windtree Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Windtree Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Comparing Ubiquiti Networks  & Its Rivals
Comparing Ubiquiti Networks & Its Rivals
Comparing Aircastle  & Its Rivals
Comparing Aircastle & Its Rivals
Analyzing Atlantic Coast Financial  and 1st Constitution Bancorp
Analyzing Atlantic Coast Financial and 1st Constitution Bancorp
CapStar Financial Holdings  Receives Average Recommendation of “Hold” from Analysts
CapStar Financial Holdings Receives Average Recommendation of “Hold” from Analysts
Litecred Trading Up 27.4% Over Last 7 Days
Litecred Trading Up 27.4% Over Last 7 Days
BROTHER Hits Market Capitalization of $166,627.00
BROTHER Hits Market Capitalization of $166,627.00


Leave a Reply

© 2006-2018 Ticker Report. Google+.